Efectivo Y Equivalentes Cambio Fecha
Abbott USD 6.8B 1.72B 2026-03
Agilent USD 1.76B 31M 2025-12
Avanos Medical USD 65.6M 24.2M 2026-03
Becton, Dickinson and Co. USD 813M 73M 2026-03
Bruker USD 133.4M 165.4M 2026-03
Cerus USD 19.96M 4.29M 2025-12
Charles River Laboratories USD 191.83M 21.94M 2026-03
Danaher USD 5.7B 1.09B 2026-03
Haemonetics USD 245.44M 117.93M 2026-03
Illumina USD 1.42B 368M 2025-12
IQVIA Holdings USD 1.95B 33M 2026-03
Merit Medical Systems USD 488.08M 41.68M 2026-03
Mettler Toledo International USD 66.89M 2.18M 2025-12
Myriad Genetics USD 124.4M 25.2M 2026-03
Neogen USD 159.9M 14.56M 2025-12
OraSure Technologies USD 176.96M 22.31M 2026-03
Pacific Biosciences Of California USD 56.27M 223.23M 2026-03
Quidel USD 140.4M 29.4M 2026-03
Revvity USD 860.32M 59.54M 2026-03
STAAR Surgical USD 153.15M 23M 2025-12
Thermo Fisher Scientific USD 3.25B 6.6B 2026-03
Waters USD 462M 125.83M 2026-03